Title: Full Text of HB2462
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HB2462 ILGA.GOV HB2462 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB2462 Introduced 2/4/2025, by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new    Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector.LRB104 08649 BDA 18702 b  A BILL FOR HB2462LRB104 08649 BDA 18702 b1    AN ACT concerning health. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Epinephrine Injector Act is amended by 5changing Sections 5 and 10 and by adding Section 25 as follows: 6    (410 ILCS 27/5)7    Sec. 5. Definitions. As used in this Act:8    "Administer" means to directly apply an epinephrine 9injector to the body of an individual.10    "Authorized entity" means any entity or organization, 11other than a school covered under Section 22-30 of the School 12Code, in connection with or at which allergens capable of 13causing anaphylaxis may be present, including, but not limited 14to, independent contractors who provide student transportation 15to schools, recreation camps, colleges and universities, day 16care facilities, youth sports leagues, amusement parks, 17restaurants, sports arenas, and places of employment. The 18Department shall, by rule, determine what constitutes a day 19care facility under this definition.20    "Authorized individual" means an individual who has 21successfully completed the training program under Section 10 22of this Act. 23    "Department" means the Department of Public Health.  HB2462- 2 -LRB104 08649 BDA 18702 b1    "Epinephrine injector" includes an auto-injector approved 2by the United States Food and Drug Administration for the 3administration of epinephrine and a pre-filled syringe 4approved by the United States Food and Drug Administration and 5used for the administration of epinephrine that contains a 6pre-measured dose of epinephrine that is equivalent to the 7dosages used in an auto-injector. 8    "Health care practitioner" means a physician licensed to 9practice medicine in all its branches under the Medical 10Practice Act of 1987, a physician assistant under the 11Physician Assistant Practice Act of 1987 with prescriptive 12authority, or an advanced practice registered nurse with 13prescribing authority under Article 65 of the Nurse Practice 14Act.15    "Pharmacist" has the meaning given to that term under 16subsection (k-5) of Section 3 of the Pharmacy Practice Act.17    "Undesignated epinephrine injector" means an epinephrine 18injector prescribed in the name of an authorized entity.19(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; 20100-799, eff. 1-1-19.) 21    (410 ILCS 27/10)22    Sec. 10. Prescription to authorized entity; use; training.23    (a) A health care practitioner may prescribe epinephrine 24injectors in the name of an authorized entity for use in 25accordance with this Act, and pharmacists and health care   HB2462- 3 -LRB104 08649 BDA 18702 b1practitioners may dispense epinephrine injectors pursuant to a 2prescription issued in the name of an authorized entity. Such 3prescriptions shall be valid for a period of 2 years.4    (b) An authorized entity may acquire and stock a supply of 5undesignated epinephrine injectors pursuant to a prescription 6issued under subsection (a) of this Section. Such undesignated 7epinephrine injectors shall be stored in a location readily 8accessible in an emergency and in accordance with the 9instructions for use of the epinephrine injectors. The 10Department may establish any additional requirements an 11authorized entity must follow under this Act.12    (c) An employee or agent of an authorized entity who is an 13authorized individual or any other other individual who is an 14authorized individual has completed training under subsection 15(d) of this Section may:16        (1) provide an epinephrine injector to any individual 17    on the property of the authorized entity whom the 18    employee, agent, or other individual believes in good 19    faith is experiencing anaphylaxis, or to the parent, 20    guardian, or caregiver of such individual, for immediate 21    administration, regardless of whether the individual has a 22    prescription for an epinephrine injector or has previously 23    been diagnosed with an allergy; or24        (2) administer an epinephrine injector to any 25    individual on the property of the authorized entity whom 26    the employee, agent, or other individual believes in good   HB2462- 4 -LRB104 08649 BDA 18702 b1    faith is experiencing anaphylaxis, regardless of whether 2    the individual has a prescription for an epinephrine 3    injector or has previously been diagnosed with an allergy.4    (d) An employee, agent, or other individual authorized 5must complete an anaphylaxis training program before he or she 6is able to provide or administer an epinephrine injector under 7this Section. Such training shall be valid for a period of 2 8years and shall be conducted by a nationally recognized 9organization experienced in training laypersons in emergency 10health treatment. The Department shall include links to 11training providers' websites on its website.12    Training shall include, but is not limited to:13        (1) how to recognize signs and symptoms of an allergic 14    reaction, including anaphylaxis;15        (2) how to administer an epinephrine injector; and16        (3) a test demonstrating competency of the knowledge 17    required to recognize anaphylaxis and administer an 18    epinephrine injector.19    Training may also include, but is not limited to:20        (A) a review of high-risk areas on the authorized 21    entity's property and its related facilities;22        (B) steps to take to prevent exposure to allergens;23        (C) emergency follow-up procedures; and24        (D) other criteria as determined in rules adopted 25    pursuant to this Act.26    Training may be conducted either online or in person. The   HB2462- 5 -LRB104 08649 BDA 18702 b1entity or individual conducting the training shall issue a 2certificate to each person who successfully completes the 3anaphylaxis training program. The Department shall approve 4training programs and list permitted training programs on the 5Department's Internet website.6(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 7    (410 ILCS 27/25 new)8    Sec. 25. Good Samaritan protections. Any act or omission 9taken in good faith pursuant to this Act by any of the 10following entities or individuals shall be considered 11emergency care, advice, or assistance under the Good Samaritan 12Act: (i) an authorized entity that possesses and makes 13available epinephrine injectors and its employees or agents; 14(ii) an authorized individual who possesses, makes available, 15and administers epinephrine injectors; (iii) a pharmacy or 16manufacturer that dispenses epinephrine injectors to an 17authorized entity or authorized individual; or (iv) an 18individual or entity that conducts the training described in 19subsection (d) of Section 10 of this Act. 20    Section 10. The Good Samaritan Act is amended by adding 21Section 66 as follows: 22    (745 ILCS 49/66 new)23    Sec. 66. Provision and administration of epinephrine   HB2462- 6 -LRB104 08649 BDA 18702 b1injectors. Any person meeting the definition of "authorized 2individual" under the Epinephrine Injector Act who acts in 3good faith to provide or administer epinephrine injectors 4pursuant to that Act, shall not, as a result of his or her acts 5or omissions, except willful and wanton misconduct on the part 6of that person, be liable to a person to whom such epinephrine 7injector is given to or administered for civil damages.


================================================================================

Raw Text:
Full Text of HB2462 ILGA.GOV HB2462 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB2462 Introduced 2/4/2025, by Rep. Maurice A. West, II SYNOPSIS AS INTRODUCED: 410 ILCS 27/5410 ILCS 27/10410 ILCS 27/25 new745 ILCS 49/66 new    Amends the Epinephrine Injector Act. Defines "authorized individual". Adds references to "authorized individual" in provisions regarding those persons who may provide or administer an epinephrine injector. Requires the issuance of a certificate upon completion of an anaphylaxis training program. Adds provisions regarding good Samaritan protections. Amends the Good Samaritan Act. Limits the liability of authorized individuals who may provide or administer an epinephrine injector.LRB104 08649 BDA 18702 b  A BILL FOR HB2462LRB104 08649 BDA 18702 b1    AN ACT concerning health. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Epinephrine Injector Act is amended by 5changing Sections 5 and 10 and by adding Section 25 as follows: 6    (410 ILCS 27/5)7    Sec. 5. Definitions. As used in this Act:8    "Administer" means to directly apply an epinephrine 9injector to the body of an individual.10    "Authorized entity" means any entity or organization, 11other than a school covered under Section 22-30 of the School 12Code, in connection with or at which allergens capable of 13causing anaphylaxis may be present, including, but not limited 14to, independent contractors who provide student transportation 15to schools, recreation camps, colleges and universities, day 16care facilities, youth sports leagues, amusement parks, 17restaurants, sports arenas, and places of employment. The 18Department shall, by rule, determine what constitutes a day 19care facility under this definition.20    "Authorized individual" means an individual who has 21successfully completed the training program under Section 10 22of this Act. 23    "Department" means the Department of Public Health.  HB2462- 2 -LRB104 08649 BDA 18702 b1    "Epinephrine injector" includes an auto-injector approved 2by the United States Food and Drug Administration for the 3administration of epinephrine and a pre-filled syringe 4approved by the United States Food and Drug Administration and 5used for the administration of epinephrine that contains a 6pre-measured dose of epinephrine that is equivalent to the 7dosages used in an auto-injector. 8    "Health care practitioner" means a physician licensed to 9practice medicine in all its branches under the Medical 10Practice Act of 1987, a physician assistant under the 11Physician Assistant Practice Act of 1987 with prescriptive 12authority, or an advanced practice registered nurse with 13prescribing authority under Article 65 of the Nurse Practice 14Act.15    "Pharmacist" has the meaning given to that term under 16subsection (k-5) of Section 3 of the Pharmacy Practice Act.17    "Undesignated epinephrine injector" means an epinephrine 18injector prescribed in the name of an authorized entity.19(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; 20100-799, eff. 1-1-19.) 21    (410 ILCS 27/10)22    Sec. 10. Prescription to authorized entity; use; training.23    (a) A health care practitioner may prescribe epinephrine 24injectors in the name of an authorized entity for use in 25accordance with this Act, and pharmacists and health care   HB2462- 3 -LRB104 08649 BDA 18702 b1practitioners may dispense epinephrine injectors pursuant to a 2prescription issued in the name of an authorized entity. Such 3prescriptions shall be valid for a period of 2 years.4    (b) An authorized entity may acquire and stock a supply of 5undesignated epinephrine injectors pursuant to a prescription 6issued under subsection (a) of this Section. Such undesignated 7epinephrine injectors shall be stored in a location readily 8accessible in an emergency and in accordance with the 9instructions for use of the epinephrine injectors. The 10Department may establish any additional requirements an 11authorized entity must follow under this Act.12    (c) An employee or agent of an authorized entity who is an 13authorized individual or any other other individual who is an 14authorized individual has completed training under subsection 15(d) of this Section may:16        (1) provide an epinephrine injector to any individual 17    on the property of the authorized entity whom the 18    employee, agent, or other individual believes in good 19    faith is experiencing anaphylaxis, or to the parent, 20    guardian, or caregiver of such individual, for immediate 21    administration, regardless of whether the individual has a 22    prescription for an epinephrine injector or has previously 23    been diagnosed with an allergy; or24        (2) administer an epinephrine injector to any 25    individual on the property of the authorized entity whom 26    the employee, agent, or other individual believes in good   HB2462- 4 -LRB104 08649 BDA 18702 b1    faith is experiencing anaphylaxis, regardless of whether 2    the individual has a prescription for an epinephrine 3    injector or has previously been diagnosed with an allergy.4    (d) An employee, agent, or other individual authorized 5must complete an anaphylaxis training program before he or she 6is able to provide or administer an epinephrine injector under 7this Section. Such training shall be valid for a period of 2 8years and shall be conducted by a nationally recognized 9organization experienced in training laypersons in emergency 10health treatment. The Department shall include links to 11training providers' websites on its website.12    Training shall include, but is not limited to:13        (1) how to recognize signs and symptoms of an allergic 14    reaction, including anaphylaxis;15        (2) how to administer an epinephrine injector; and16        (3) a test demonstrating competency of the knowledge 17    required to recognize anaphylaxis and administer an 18    epinephrine injector.19    Training may also include, but is not limited to:20        (A) a review of high-risk areas on the authorized 21    entity's property and its related facilities;22        (B) steps to take to prevent exposure to allergens;23        (C) emergency follow-up procedures; and24        (D) other criteria as determined in rules adopted 25    pursuant to this Act.26    Training may be conducted either online or in person. The   HB2462- 5 -LRB104 08649 BDA 18702 b1entity or individual conducting the training shall issue a 2certificate to each person who successfully completes the 3anaphylaxis training program. The Department shall approve 4training programs and list permitted training programs on the 5Department's Internet website.6(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 7    (410 ILCS 27/25 new)8    Sec. 25. Good Samaritan protections. Any act or omission 9taken in good faith pursuant to this Act by any of the 10following entities or individuals shall be considered 11emergency care, advice, or assistance under the Good Samaritan 12Act: (i) an authorized entity that possesses and makes 13available epinephrine injectors and its employees or agents; 14(ii) an authorized individual who possesses, makes available, 15and administers epinephrine injectors; (iii) a pharmacy or 16manufacturer that dispenses epinephrine injectors to an 17authorized entity or authorized individual; or (iv) an 18individual or entity that conducts the training described in 19subsection (d) of Section 10 of this Act. 20    Section 10. The Good Samaritan Act is amended by adding 21Section 66 as follows: 22    (745 ILCS 49/66 new)23    Sec. 66. Provision and administration of epinephrine   HB2462- 6 -LRB104 08649 BDA 18702 b1injectors. Any person meeting the definition of "authorized 2individual" under the Epinephrine Injector Act who acts in 3good faith to provide or administer epinephrine injectors 4pursuant to that Act, shall not, as a result of his or her acts 5or omissions, except willful and wanton misconduct on the part 6of that person, be liable to a person to whom such epinephrine 7injector is given to or administered for civil damages.